文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

慢性肾脏病风险类别进展与心血管疾病和全因死亡率的关系:年轻人冠状动脉风险发展队列研究。

Progression of Chronic Kidney Disease Risk Categories and Risk of Cardiovascular Disease and Total Mortality: Coronary Artery Risk Development in Young Adults Cohort.

机构信息

Division of Epidemiology and Community Health School of Public Health University of Minnesota Minneapolis MN.

Division of Cardiology and Department of Medicine, Hennepin Healthcare University of Minnesota Medical School Minneapolis MN.

出版信息

J Am Heart Assoc. 2022 Nov;11(21):e026685. doi: 10.1161/JAHA.122.026685. Epub 2022 Oct 31.


DOI:10.1161/JAHA.122.026685
PMID:36314497
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9673645/
Abstract

Background Previous studies of worsening chronic kidney disease (CKD) based on declining estimated glomerular filtration rate (eGFR) or increasing urine albumin-creatinine ratio (UACR) are limited to later middle-age and older adults. We examined associations of CKD progression and incident cardiovascular disease (CVD) and mortality in younger adults. Methods and Results We studied 4382 adults in CARDIA (Coronary Artery Risk Development in Young Adults) initially aged 27 to 41 years and prospectively over 20 years. Five-year transition probabilities across CKD risk categories were based on eGFR and UACR measured at each exam. Proportional hazards models predicted incident CVD and all-cause mortality by time-varying CKD risk category, adjusting for demographics and CVD risk factors. Progression of CKD risk categories over 20 years occurred in 28.7% (1256/4382) of participants, driven by increases in UACR, but including 5.8% (n=255) with eGFR<60 mL/min per 1.73 m or UACR ≥300 mg/g. Compared with eGFR ≥60 and UACR <10, demographic and smoking-adjusted hazard ratios for CVD were 1.62 (95% CI, 1.21-2.18) for low CKD risk (eGFR ≥60 with UACR 10-29) and 13.65 (95% CI, 7.52-24.79) for very high CKD risk (eGFR <30 or eGFR 30-44 with UACR 30-299; or eGFR 30-59 with UACR ≥300). Corresponding hazard ratios for all-cause mortality were 1.42 (95% CI, 1.08-1.88) and 14.75 (95% CI, 9.97-21.82). Although CVD associations were attenuated after adjustment for mediating CVD risk factors, all-cause mortality associations remained statistically significant. Conclusions Among young to middle-aged adults, progression to higher CKD risk category was common. Routine monitoring eGFR and UACR holds promise for prevention of CVD and total mortality.

摘要

背景:基于估算肾小球滤过率 (eGFR) 下降或尿白蛋白/肌酐比值 (UACR) 升高的慢性肾脏病 (CKD) 恶化的先前研究仅限于中老年人群。我们研究了年轻成年人 CKD 进展和心血管疾病 (CVD) 及死亡率的发生率。

方法和结果:我们对 4382 名在 CARDIA(年轻人冠状动脉风险发展研究)中年龄在 27 至 41 岁的成年人进行了研究,并前瞻性随访 20 年。在每次检查时测量 eGFR 和 UACR,基于这些数据确定 5 年 CKD 风险类别转变概率。通过时变 CKD 风险类别预测 CVD 和全因死亡率,调整了人口统计学和 CVD 危险因素。在 20 年的时间里,28.7%(4382 名参与者中的 1256 名)的参与者出现了 CKD 风险类别的进展,这主要是由 UACR 的增加引起的,但其中包括 5.8%(n=255)的患者 eGFR<60 mL/min/1.73 m 或 UACR≥300 mg/g。与 eGFR≥60 和 UACR<10 相比,在调整了人口统计学和吸烟因素后,CVD 的危险比为低 CKD 风险(eGFR≥60 且 UACR 为 10-29)为 1.62(95%CI,1.21-2.18),而极高 CKD 风险(eGFR<30 或 eGFR 30-44 且 UACR 为 30-299;或 eGFR 30-59 且 UACR≥300)为 13.65(95%CI,7.52-24.79)。全因死亡率的相应危险比为 1.42(95%CI,1.08-1.88)和 14.75(95%CI,9.97-21.82)。尽管在调整了中介 CVD 危险因素后,CVD 相关性减弱,但全因死亡率相关性仍然具有统计学意义。

结论:在年轻至中年成年人中,向更高的 CKD 风险类别进展很常见。常规监测 eGFR 和 UACR 有望预防 CVD 和全因死亡率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d193/9673645/8205300840b4/JAH3-11-e026685-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d193/9673645/3d41e830a143/JAH3-11-e026685-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d193/9673645/8205300840b4/JAH3-11-e026685-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d193/9673645/3d41e830a143/JAH3-11-e026685-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d193/9673645/8205300840b4/JAH3-11-e026685-g002.jpg

相似文献

[1]
Progression of Chronic Kidney Disease Risk Categories and Risk of Cardiovascular Disease and Total Mortality: Coronary Artery Risk Development in Young Adults Cohort.

J Am Heart Assoc. 2022-11

[2]
Kidney Function as Risk Factor and Predictor of Cardiovascular Outcomes and Mortality Among Older Adults.

Am J Kidney Dis. 2021-3

[3]
Association of estimated glomerular filtration rate and urine albumin-to-creatinine ratio with incidence of cardiovascular diseases and mortality in chinese patients with type 2 diabetes mellitus - a population-based retrospective cohort study.

BMC Nephrol. 2017-2-2

[4]
Kidney disease progression and all-cause mortality across estimated glomerular filtration rate and albuminuria categories among patients with vs. without type 2 diabetes.

BMC Nephrol. 2020-5-7

[5]
Chronic kidney disease, cardiovascular disease and mortality: A prospective cohort study in a multi-ethnic Asian population.

Eur J Prev Cardiol. 2015-8

[6]
Comparison between urine albumin-to-creatinine ratio and urine protein dipstick testing for prevalence and ability to predict the risk for chronic kidney disease in the general population (Iwate-KENCO study): a prospective community-based cohort study.

BMC Nephrol. 2016-5-12

[7]
Impact of chronic kidney disease on the prevalence of cardiovascular disease in patients with type 2 diabetes in Spain: PERCEDIME2 study.

BMC Nephrol. 2014-9-16

[8]
Nontraditional Risk Factors for Progression Through Chronic Kidney Disease Risk Categories: The Coronary Artery Risk Development in Young Adults Study.

Am J Med. 2023-4

[9]
Changes in GFR and Albuminuria in Routine Clinical Practice and the Risk of Kidney Disease Progression.

Am J Kidney Dis. 2021-9

[10]
Chronic Kidney Disease Stage and Cardiovascular and Mortality Events Among Older Adults: The SPRINT Trial.

Kidney Med. 2024-5-18

引用本文的文献

[1]
Diabetic kidney disease phenotypes and the risk of cardiovascular events: The Silesia Diabetes-Heart Project.

Cardiovasc Diabetol. 2025-7-30

[2]
Atherosclerotic Cardiovascular Disease Risk Estimates Using the New Predicting Risk of Cardiovascular Disease Events Equations: Implications for Statin Use.

Curr Cardiol Rep. 2025-7-2

[3]
Inflammatory and Cardiovascular Events in CKD: The Multi-Ethnic Study of Atherosclerosis (MESA).

Am J Kidney Dis. 2025-5-15

[4]
Urinary albumin-to-creatinine ratio for predicting risk of all-cause mortality and specific-cause mortality in patients with rheumatoid arthritis: evidence from NHANES 1999-2018.

Clin Rheumatol. 2025-2

[5]
Effects of Once-Weekly Semaglutide on Kidney Disease Outcomes by KDIGO Risk Category in the SUSTAIN 6 Trial.

Kidney Int Rep. 2024-5-22

[6]
Cardiovascular and Mortality Risks in Young Health Screening Examinees With Marginal Estimated GFR.

Kidney Int Rep. 2023-9-7

[7]
CKD Progression Prediction in a Diverse US Population: A Machine-Learning Model.

Kidney Med. 2023-6-24

[8]
Racial Differences and Contributory Cardiovascular and Non-Cardiovascular Risk Factors Towards Chronic Kidney Disease Progression.

Vasc Health Risk Manag. 2023

[9]
Cardiovascular Calcification Heterogeneity in Chronic Kidney Disease.

Circ Res. 2023-4-14

[10]
Nontraditional Risk Factors for Progression Through Chronic Kidney Disease Risk Categories: The Coronary Artery Risk Development in Young Adults Study.

Am J Med. 2023-4

本文引用的文献

[1]
A Unifying Approach for GFR Estimation: Recommendations of the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease.

J Am Soc Nephrol. 2021-12-1

[2]
Time-Updated Changes in Estimated GFR and Proteinuria and Major Adverse Cardiac Events: Findings from the Chronic Renal Insufficiency Cohort (CRIC) Study.

Am J Kidney Dis. 2022-1

[3]
Incorporating kidney disease measures into cardiovascular risk prediction: Development and validation in 9 million adults from 72 datasets.

EClinicalMedicine. 2020-10-14

[4]
Nomenclature for Kidney Function and Disease: Executive Summary and Glossary From a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference.

Am J Kidney Dis. 2020-8

[5]
Kidney disease progression and all-cause mortality across estimated glomerular filtration rate and albuminuria categories among patients with vs. without type 2 diabetes.

BMC Nephrol. 2020-5-7

[6]
Fasting glucose and insulin resistance trajectories during young adulthood and mid-life cardiac structure and function.

J Diabetes Complications. 2019-2-6

[7]
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Circulation. 2019-3-17

[8]
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Circulation. 2018-11-10

[9]
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.

Lancet. 2018-11-8

[10]
Trends in Albuminuria and GFR Among Adolescents in the United States, 1988-2014.

Am J Kidney Dis. 2018-7-14

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索